Advertisement

Diagnosis of cardiovascular autonomic neuropathy in diabetes: as simple as possible, but not simpler? An answer

  • G. BaxEmail author
  • F. Bellavere
Letter to the Editor
  • 51 Downloads

Dear Editor,

We read the interesting letter of K. Pafili and N. Papanas commenting on our recent paper on autonomic testing [1]. We appreciated that they reached somewhat similar conclusions in a previous work [2]: i.e., the association of HRV on Valsalva manoeuvre (VM) and on lying to standing (LS) is the most reliable tests for autonomic dysfunctions, although we found VM more sensitive than LS, in contrast to what they found.

However, we need to underline an important feature of our work: it is based on the ability of each test to recognize the presence “in the real world” of autonomic neuropathy, i.e., documented by the relief of postural hypotension. This marks an important difference from other previously published papers cited by K. Pafili and N. Papanas which, however, were based on “self-controlled” calculations within the five Ewing’s tests: i.e., comparing the sensitivity (and specificity) of each test with the other tests in cross correlations within the battery itself in a questionable “closed loop”.

Moreover, the clinical utility of VM and LS which we found pivotal in autonomic testing is confirmed by the paper of May and Arildsen [3] which shows the high independent predicting mortality value of VM and LS, while the deep breathing test results useless; just on the line and confirming what recently has come from the DIAD study, as mentioned in our paper [4, 5]. Therefore, at least one question arises from our paper and other recent evidences: is it necessary to use the deep breathing test anymore?

Hence, following our approach, the diagnosis in cardiovascular autonomic neuropathy results, we would say, simpler and clearer too.

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was required before testing and obtained from any patient.

References

  1. 1.
    Bellavere F, Ragazzi E, Chilelli NC, Lapolla A, Bax G (2018) Autonomic testing: which value for each cardiovascular test? An observational study. Acta Diabetol.  https://doi.org/10.1007/s00592-018-1215-y. (Epub ahead of print) Google Scholar
  2. 2.
    Pafili K, Trypsianis G, Papazoglou D, Maltezos E, Papanas N (2015) Simplified diagnosis of cardiovascular autonomic neuropathy in type 2 diabetes using Ewing’s battery. Rev Diabet Stud 12(1–2):213–219CrossRefGoogle Scholar
  3. 3.
    May O, Arildsen H (2011) Long-term predictive power of simple function tests for cardiovascular autonomic neuropathy in diabetes: a population-based study. Acta Diabetol 48(4):311–316CrossRefGoogle Scholar
  4. 4.
    Chyun DA, Wackers FJ, Inzucchi SE et al (2015) Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study. SAGE Open Med 3:2050312114568476CrossRefGoogle Scholar
  5. 5.
    Cha SA, Yun JS, Lim TS et al (2016) Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One 11(10):e0164807CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2019

Authors and Affiliations

  1. 1.Diabetic Clinic USL 6 EuganeaDIMED University of PadovaPaduaItaly
  2. 2.Endocrinology and Diabetes section “Rizzola” Foundation HospitalSan DonàItaly

Personalised recommendations